SHA:688271

Shanghai United Imaging Healthcare H1 Profit Down 10%, Revenue Climbs 17%

Shanghai United Imaging Healthcare (SHA:688271) posted first-half attributable net profit of 897.0 million yuan, down 10% from 998.0 million yuan the previous year.Earnings per share slipped to 1.10 yuan from 1.21 yuan, according to Thursday filings with the Shanghai bourse.Operating revenue climbed 17% year over year to 7.05 billion yuan from 6.02 billion yuan.The medical imaging systems and equipment maker declared an interim dividend of 1.30 yuan per 10 shares.Shares of the company rose 1% in recent trade.

Nomura Adjusts Shanghai United Imaging Healthcare's Price Target to 143.48 Yuan From 137.60 Yuan, Keeps at Buy

Shanghai United Imaging Healthcare (SHA:688271) has an average rating of buy and mean price target of 162.16 yuan, according to analysts polled by FactSet.

China Medical Equipment Procurement Drops 32% in April, Jefferies Reports

Medical equipment procurement in Chinese hospitals fell 32% year-over-year in April, driven by the impact of a demanding comparison base in the first quarter of 2025 and volume-based procurement policies, Jefferies said in a note Monday.The April decline marks a deepening slowdown from the 14% drop in the first quarter of 2026.United Imaging Healthcare's (SHA:688271) hospital procurement sales fell 47% in April due to the prior year's elevated baseline, Jefferies said.Amid the decline, domestic hospital equipment maker Shenzhen Mindray Bio-Medical Electronics (SHE:300760) saw a 15% sales growth, especially in the ultrasound and patient monitoring and life support segments, during the month.GE Healthcare's China sales were in line with expectations. While the equipment maker forecasts lower sales in 2026, it sees a more stable China market, and Jefferies also expects improvement in 2027.

Nomura Upgrades Shanghai United Imaging Healthcare to Buy From Neutral, Adjusts Price Target to 137.60 Yuan From 132.64 Yuan